Business Standard

Saturday, January 04, 2025 | 09:46 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Indian-origin Vasant Narasimhan to head $48 billion pharma giant Novartis

At present, he holds the post of global head of drug development and chief medical officer

Vasant Narasimhan, Novartis global CEO
Premium

Novartis CEO Vasant Narasimhan. Photo: www.novartis.com

Aneesh Phadnis Mumbai
Vasant (Vas) Narasimhan has been named as the global chief executive officer (CEO) of  the Swiss pharmaceutical giant Novartis, making him the first Indian origin person to hold the post in a large pharma multinational.

Narasimhan, 41, a doctor from Harvard Medical School, is a second-generation immigrant in the US. His parents moved there from Tamil Nadu in the 1970s. He has been with Novartis since 2005. At present, he holds the post of global head of drug development and chief medical officer and will assume the new post from February. Before joining Novartis, he worked at McKinsey & Co.

Narasimhan replaces

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in